Press Release Healthcare/Medical Devices June 17, 2025 1 min read

Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt

Corvia Medical, a heart failure treatment company, raised $55 million from existing investors to complete the RESPONDER-HF trial and pursue FDA approval for its Corvia Atrial Shunt device.

Third Rock Ventures General Catalyst Partners AccelMed Lumira Ventures Strategic Investor 1 Strategic Investor 2 Corvia Medical Inc

Press ReleaseJune 17, 2025

Corvia Medical, a heart failure treatment company, raised $55 million from existing investors to complete the RESPONDER-HF trial and pursue FDA approval for its Corvia Atrial Shunt device.

Press ReleaseMay 8, 2026

West Enclave Merger Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 13, 2026

May 8, 2026

Press ReleaseMay 8, 2026

Shreya Acquisition Group Announces Closing of $110 Million Initial Public Offering (Including Partial Exercise of Over-Allotment Option)

May 8, 2026

Press ReleaseMay 8, 2026

Con Edison Announces $2 Billion At-The-Market (ATM) Equity Offering Program

May 8, 2026

← Back to all articles

Generated by Yeal

Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt

Related articles

West Enclave Merger Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 13, 2026

Shreya Acquisition Group Announces Closing of $110 Million Initial Public Offering (Including Partial Exercise of Over-Allotment Option)

Con Edison Announces $2 Billion At-The-Market (ATM) Equity Offering Program